A company built around the cost of elective care
Todd Watts and Scott Jorgensen co-founded PatientFi in July 2017. In an early interview with the Octane business accelerator, Watts described spending roughly eighteen months building the platform and obtaining licences before 2019 became its first commercial year. The company was designed for medical practices offering procedures patients often pay for themselves, with a digital application and monthly payments presented alongside the treatment price. [1]
Expansion brought additional capital and a wider set of services. In February 2024, Questa Capital led a growth-equity financing. Its current portfolio page describes PatientFi as a healthcare-technology company providing engagement, payment and financing tools, and says the practice network has grown to more than 11,500 locations since 2019. That is an investor's undated network claim reviewed in October 2026, not an independently audited count of practices funding loans each month. [2]
The modern business is easy to understand at a high level: a practice wants to be paid for an elective procedure, and a patient wants to spread the cost. Its most important detail is easier to miss. Some advertised no-interest plans are loans. Interest is waived only when the required payoff condition is met.
PatientFi administers the program; banks make the loans
PatientFi's official lending-partners page says the company is not a bank and names Lead Bank and Optum Bank, Inc. as current bank partners. It identifies PatientFi, Inc. as program administrator and servicer on behalf of participating financial institutions. The brand at the front of the transaction is therefore different from the institution making the loan. [3]
The distinction matters to a patient trying to understand an offer and to a reader assessing the business. Administration can include technology, payment management and customer contact without making the administrator a deposit-taking bank. Funding a loan, servicing it and eventually owning its repayment stream are also different roles. The public partner page is not a complete disclosure of who retains every dollar of risk after origination.
This profile concerns the company at patientfi.com and its support.patientfi.com help centre. Its website identifies an Irvine, California address and NMLS number 1719196. Similar-looking names on other domains are not used as evidence for its prices, lending partners or corporate history. [4]
An approval is followed by a separate transaction
The patient first applies through a participating provider. The May 12, 2026 support FAQ says the application uses a soft credit inquiry and considers factors including credit score, payment history and debt relative to income. An approved spending limit lasts 120 days. The provider then submits a transaction for the patient to review and accept, including a choice of payment plan. Each new transaction opens a separate loan. [5]
Those steps distinguish the opportunity to borrow from an actual obligation. A person can qualify for a limit without immediately using all of it. Once a loan is opened, the FAQ says the balance and repayment history are reported to credit bureaus. A soft application inquiry therefore does not mean later borrowing is invisible to a credit report or that missed payments cannot matter. [5]
The company's general information page describes procedure amounts from $200 to $50,000 and says no application fee is charged. It markets the service across specialties including aesthetics, dental care, fertility, vision and audiology. Eligibility, the provider's available plans and the actual transaction determine the offer; the upper end of an advertised range is not a commitment to lend that amount to every applicant. [4]
The two ways a monthly payment can be priced
Fixed-rate financing and a promotional loan have different mechanics. PatientFi's partner disclosure illustrates a $1,000, twelve-month fixed-rate loan with ranging from 6.99% to 32.99%. The lowest advertised rate assumes excellent credit and enrollment in automatic payments. A longer term can reduce the monthly installment while increasing total repayment. The advertised starting rate is not the average rate paid by borrowers. [3]
The promotional offer works differently. PatientFi says the promotional period begins when the provider is funded. Interest accrues during that period and is waived only if the purchase balance is fully paid before the deadline. Paying the required minimum is not enough to retire the balance within the promotion. This is why the company presents a suggested payment above the minimum. [6]
For a clearly labeled company example, a $1,000 six-month promotion at 32.99% APR has suggested payments of about $166.67. Its disclosure estimates total repayment of $1,000 if the promotional condition is met. If only the minimum payments are made, its illustrated longer schedule produces an estimated total cost of $2,013.44. These are the company's illustrative scenarios, not a quotation for a particular applicant. [3]
The important difference is not a small-print technicality. Keeping an account current by paying its minimum can still leave promotional interest payable. A household can avoid a late payment and nevertheless fail to qualify for the interest waiver. The relevant comparison includes the full price, deadline, required payoff amount and fallback terms, rather than the promotional monthly number alone.
What the provider receives
PatientFi's provider FAQ says funds typically appear within one to three business days after being requested, and that practices can request funds ahead of a procedure. It directs practices to the company for current merchant-processing rates rather than publishing a universal fee. It also says a patient's missed payment does not itself produce a penalty or fee for the practice. These are stated program features, not a disclosure of every duty in a provider's contract. [4]
The arrangement can reduce the delay between a practice selling treatment and collecting cash. But three separate events remain: the practice is funded, the patient receives the service, and the patient repays. When funding comes ahead of treatment, a cancellation or change requires accurate communication between the service provider and financing administrator. An absence of ordinary borrower-default recourse does not establish immunity from service disputes, fraud or contractual refund duties.
From the practice's perspective, the economic question is whether the financing generates worthwhile additional treatment after its cost. From the patient's perspective, it is whether the treatment and repayment schedule fit their circumstances. A higher acceptance rate can serve the first goal without proving the second. Neither loan approval nor a clinician's willingness to offer financing is a finding of medical necessity.
Servicing details become important after the sale
PatientFi's support centre says there is no prepayment penalty and describes a 0.25-percentage-point discount for automatic payments. It also distinguishes fixed-rate loans, whose due date can be changed once, from promotional loans, whose contractual due date cannot be changed through that option. A payment preference and a promotional payoff requirement are separate matters. [5]
The spending-limit help page says an increase can be requested after thirty days and is subject to a fresh credit assessment. Existing balances reduce the amount available for additional treatment. The example it provides is a $5,000 approval with $2,000 already owed, leaving $3,000 for new spending. This is available capacity, not forgiveness of the existing loan. [7]
Repeated use can consequently create multiple loans with distinct balances and dates. The support FAQ explicitly says they cannot be merged. Convenience at the application stage does not remove the need to track each obligation through repayment. [5]
What remains private, and what the evidence can support
The reviewed public materials provide substantial detail about terms and workflow but do not disclose audited annual revenue, profitability, total funded originations, the complete funding structure or comparable mature loss cohorts. The practice-network claim and private-company growth rankings cannot fill those gaps. Nor do testimonials establish the share of borrowers who earn the full promotional waiver.
That missing denominator is especially consequential here. Without knowing how many promotional borrowers repay within the deadline, a reader cannot infer the average realized financing cost from a zero-interest advertisement. Equally, an expensive fallback example is not evidence that every patient pays that amount. Both favorable and unfavorable scenarios need to remain scenarios until outcome data are available.
The Consumer Financial Protection Bureau's May 2023 medical-financing report describes industry concerns about promotions, financial burdens and credit offered during healthcare decisions. It is not an enforcement finding against PatientFi. [8] The company's central opportunity and risk sit together: it can make the timing of an elective expense easier to manage, while the eventual cost still depends on product selection and repayment.
PatientFi's history is therefore more than a story about quicker approvals. It is a business connecting medical providers, consumers and outside financial institutions, with the platform managing the relationship after treatment is sold. Its lending disclosures make one conclusion unusually clear: no interest if paid in full is a conditional benefit, not an unconditional zero- promise.
Sources
- Octane, interview with PatientFi co-founder Todd Watts and founding historySourceBack to text: ↑
- Questa Capital, PatientFi investment history and practice-network claimSourceBack to text: ↑
- PatientFi, current bank partners and loan repayment examplesSourceBack to text: ↑1↑2↑3
- PatientFi, company and provider informationSourceBack to text: ↑1↑2↑3
- PatientFi, General FAQ, updated May 12, 2026SourceBack to text: ↑1↑2↑3↑4
- PatientFi, fixed-rate and deferred-interest promotional disclosuresSourceBack to text: ↑
- PatientFi, spending-limit increase explanation, February 4, 2026SourceBack to text: ↑
- CFPB, Medical Credit Cards and Financing Plans, May 4, 2023Official sourceBack to text: ↑